162 related articles for article (PubMed ID: 38238294)
21. Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study.
Zhao Y; Fang LT; Shen TW; Choudhari S; Talsania K; Chen X; Shetty J; Kriga Y; Tran B; Zhu B; Chen Z; Chen W; Wang C; Jaeger E; Meerzaman D; Lu C; Idler K; Ren L; Zheng Y; Shi L; Petitjean V; Sultan M; Hung T; Peters E; Drabek J; Vojta P; Maestro R; Gasparotto D; Kõks S; Reimann E; Scherer A; Nordlund J; Liljedahl U; Foox J; Mason CE; Xiao C; Hong H; Xiao W
Sci Data; 2021 Nov; 8(1):296. PubMed ID: 34753956
[TBL] [Abstract][Full Text] [Related]
22. Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers.
Pritchard AL; Johansson PA; Nathan V; Howlie M; Symmons J; Palmer JM; Hayward NK
PLoS One; 2018; 13(4):e0194098. PubMed ID: 29641532
[TBL] [Abstract][Full Text] [Related]
23. multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples.
Josephidou M; Lynch AG; Tavaré S
Nucleic Acids Res; 2015 May; 43(9):e61. PubMed ID: 25722372
[TBL] [Abstract][Full Text] [Related]
24. [Precision diagnostics and therapy in hematological malignancies].
Hellström Lindberg E; Cavelier L; Cammenga J; Andersson PO; Fioretos T; Rosenquist R
Lakartidningen; 2021 May; 118():. PubMed ID: 33973223
[TBL] [Abstract][Full Text] [Related]
25. Implementation of an NGS-based sequencing and gene fusion panel for clinical screening of patients with suspected hematologic malignancies.
Levy MA; Santos S; Kerkhof J; Stuart A; Aref-Eshghi E; Guo F; Hedley B; Wong H; Rauh M; Feilotter H; Berardi P; Semenuk L; Yang P; Knoll J; Ainsworth P; McLachlin CM; Chin-Yee I; Kovacs M; Deotare U; Lazo-Langner A; Hsia C; Keeney M; Xenocostas A; Howlett C; Lin H; Sadikovic B
Eur J Haematol; 2019 Sep; 103(3):178-189. PubMed ID: 31177553
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease testing in hematologic malignancies and solid cancer.
Ben Lassoued A; Nivaggioni V; Gabert J
Expert Rev Mol Diagn; 2014 Jul; 14(6):699-712. PubMed ID: 24938122
[TBL] [Abstract][Full Text] [Related]
27. A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies.
Hiemenz MC; Oberley MJ; Doan A; Aye L; Ji J; Schmidt RJ; Biegel JA; Bhojwani D; Raca G
Cancer Genet; 2021 Jun; 254-255():25-33. PubMed ID: 33571894
[TBL] [Abstract][Full Text] [Related]
28. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
29. Halvade somatic: Somatic variant calling with Apache Spark.
Decap D; de Schaetzen van Brienen L; Larmuseau M; Costanza P; Herzeel C; Wuyts R; Marchal K; Fostier J
Gigascience; 2022 Jan; 11(1):. PubMed ID: 35022699
[TBL] [Abstract][Full Text] [Related]
30. The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
Bench AJ; Erber WN; Scott MA
Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
[TBL] [Abstract][Full Text] [Related]
32. GeDi: applying suffix arrays to increase the repertoire of detectable SNVs in tumour genomes.
Coleman I; Corleone G; Arram J; Ng HC; Magnani L; Luk W
BMC Bioinformatics; 2020 Feb; 21(1):45. PubMed ID: 32024475
[TBL] [Abstract][Full Text] [Related]
33. Pan-cancer analysis of whole genomes.
ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
[TBL] [Abstract][Full Text] [Related]
34. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples.
Bailey MH; Meyerson WU; Dursi LJ; Wang LB; Dong G; Liang WW; Weerasinghe A; Li S; Li Y; Kelso S; ; ; Saksena G; Ellrott K; Wendl MC; Wheeler DA; Getz G; Simpson JT; Gerstein MB; Ding L;
Nat Commun; 2020 Sep; 11(1):4748. PubMed ID: 32958763
[TBL] [Abstract][Full Text] [Related]
35. Whole genome sequencing analysis for cancer genomics and precision medicine.
Nakagawa H; Fujita M
Cancer Sci; 2018 Mar; 109(3):513-522. PubMed ID: 29345757
[TBL] [Abstract][Full Text] [Related]
36. Pan-cancer whole-genome analyses of metastatic solid tumours.
Priestley P; Baber J; Lolkema MP; Steeghs N; de Bruijn E; Shale C; Duyvesteyn K; Haidari S; van Hoeck A; Onstenk W; Roepman P; Voda M; Bloemendal HJ; Tjan-Heijnen VCG; van Herpen CML; Labots M; Witteveen PO; Smit EF; Sleijfer S; Voest EE; Cuppen E
Nature; 2019 Nov; 575(7781):210-216. PubMed ID: 31645765
[TBL] [Abstract][Full Text] [Related]
37. The role of molecular genetic analysis within the diagnostic haemato-oncology laboratory.
Bench AJ
Int J Lab Hematol; 2012 Feb; 34(1):21-34. PubMed ID: 21883966
[TBL] [Abstract][Full Text] [Related]
38. Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data.
do Valle ÍF; Giampieri E; Simonetti G; Padella A; Manfrini M; Ferrari A; Papayannidis C; Zironi I; Garonzi M; Bernardi S; Delledonne M; Martinelli G; Remondini D; Castellani G
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):341. PubMed ID: 28185561
[TBL] [Abstract][Full Text] [Related]
39. Strelka2: fast and accurate calling of germline and somatic variants.
Kim S; Scheffler K; Halpern AL; Bekritsky MA; Noh E; Källberg M; Chen X; Kim Y; Beyter D; Krusche P; Saunders CT
Nat Methods; 2018 Aug; 15(8):591-594. PubMed ID: 30013048
[TBL] [Abstract][Full Text] [Related]
40. A cancer cell-line titration series for evaluating somatic classification.
Denroche RE; Mullen L; Timms L; Beck T; Yung CK; Stein L; McPherson JD; Brown AM
BMC Res Notes; 2015 Dec; 8():823. PubMed ID: 26708082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
